At a glance
- Originator Kissei Pharmaceutical
- Class Small molecules
- Mechanism of Action Beta 2 adrenergic receptor agonists; Beta 3 adrenergic receptor agonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Genitourinary disorders